Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

A role for protein kinase CK2 in cell proliferation: evidence using a kinase-inactive mutant of CK2 catalytic subunit α

Abstract

Protein kinase CK2 is an ubiquitous and pleiotropic Ser/Thr protein kinase composed of two catalytic (α and/or α′) and two regulatory (β) subunits generally combined to form α2β2, αα′β2, or α′2β2 heterotetramers. To gain more insight into the role of CK2 in the control of proliferation in mammalian cells, overexpression of isolated CK2 subunits α, α′, or β was carried out in two fibroblast cell lines: NIH3T3 and CCL39. To interfere with CK2 cellular functions, cells were also transfected with a kinase-inactive mutant of CK2α catalytic subunit: CK2α-K68A. In NIH3T3 cells, overexpression of either wild-type subunit (α, α′ or β) had no effect on cell proliferation. In contrast, overexpression of the CK2α kinase-deficient mutant induced a marked inhibition of cell proliferation. This resulted from a defect in G1/S progression as demonstrated in transient transfection experiments in both NIH3T3 and CCL39 cells using BrdU incorporation measurements and in CCL39 clones stably overexpressing the CK2α-K68A mutant by growth curve analysis. We demonstrated that the kinase-negative mutant has the capacity to integrate the endogenous CK2 subunit pool both as an isolated kinase-inactive α subunit and as associated to the β subunit in a kinase-inactive tetramer. Finally we showed that expression of the kinase-inactive mutant interferes with phosphorylation of an endogenous CK2 substrate; we speculate that optimal phosphorylation of target proteins by CK2 is required to achieve optimal cell cycle progression.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

Abbreviations

AEBSF:

4-(2-aminoethyl)-benzenesulfonyl fluoride

DMEM:

Dulbecco's modified Eagle's Medium

FCS:

fetal calf serum

PBS:

phosphate-buffered saline

SDS–PAGE:

sodium dodecyl sulfate polyacrylamide gel electrophoresis.

References

  • Allende JE, Allende CC . 1995 FASEB J. 9: 313–323

  • Bidwai AP, Reed JC, Glover CV . 1993 Arch. Biochem. Biophys. 300: 265–270

  • Boldyreff B, Issinger OG . 1997 FEBS Lett. 403: 197–199

  • Chantalat L, Leroy D, Filhol O, Nueda A, Benitez MJ, Chambaz EM, Cochet C, Dideberg O . 1999 EMBO J. 18: 2930–2940

  • Chen M, Li D, Krebs EG, Cooper JA . 1997 Mol. Cell. Biol. 17: 1904–1912

  • Cosmelli D, Antonelli M, Allende CC, Allende JE . 1997 FEBS Lett. 410: 391–396

  • Dobrowolska G, Meggio F, Szczegielniak J, Muszynska G, Pinna LA . 1992 Eur. J. Biochem. 204: 299–303

  • Egyhazi E, Ossoinak A, Filhol-Cochet O, Cochet C, Pigon A . 1999 Mol. Cell. Biochem. 191: 149–159

  • Filhol O, Cochet C, Wedegaertner P, Gill GN, Chambaz EM . 1991 Biochemistry 30: 11133–11140

  • Glover CV . 1998 Prog. Nucleic Acid. Res. Mol. Biol. 59: 95–133

  • Groom LA, Sneddon AA, Alessi DR, Dowd S, Keyse SM . 1996 EMBO J. 15: 3621–3632

  • Hagemann C, Kalmes A, Wixler V, Wixler L, Schuster T, Rapp UR . 1997 FEBS Lett. 403: 200–202

  • Hanks SK, Hunter T . 1995 FASEB J. 9: 576–596

  • Hanna DE, Rethinaswamy A, Glover CV . 1995 J. Biol. Chem. 270: 25905–25914

  • Heriche JK, Lebrin F, Rabilloud T, Leroy D, Chambaz EM, Goldberg Y . 1997 Science 276: 952–955

  • Herskowitz I . 1987 Nature 329: 219–222

  • Kikkawa U, Mann SK, Firtel RA, Hunter T . 1992 Mol. Cell. Biol. 12: 5711–5723

  • Korn I, Gutkind S, Srinivasan N, Blundell TL, Allende CC, Allende JE . 1999 Mol. Cell. Biochem. 191: 75–83

  • Lebrin F, Bianchini L, Rabilloud T, Chambaz EM, Goldberg Y . 1999 Mol. Cell. Biochem. 191: 207–212

  • Li D, Dobrowolska G, Aicher LD, Chen M, Wright JH, Drueckes P, Dunphy EL, Munar ES, Krebs EG . 1999 J. Biol. Chem. 274: 32988–32996

  • Litchfield DW, Dobrowolska G, Krebs EG . 1994 Cell. Mol. Biol. Res. 40: 373–381

  • Lorenz P, Ackermann K, Simoes-Wuest P, Pyerin W . 1999 FEBS Lett. 448: 283–288

  • Lorenz P, Pepperkok R, Ansorge W, Pyerin W . 1993 J. Biol. Chem. 268: 2733–2739

  • Meggio F, Boldyreff B, Issinger OG, Pinna LA . 1994 Biochemistry 33: 4336–4342

  • Niefind K, Guerra B, Pinna LA, Issinger OG, Schomburg D . 1998 EMBO J. 17: 2451–2462

  • Orlandini M, Semplici F, Ferruzzi R, Meggio F, Pinna LA, Oliviero S . 1998 J. Biol. Chem. 273: 21291–21297

  • Padmanabha R, Chen-Wu JL, Hanna DE, Glover CV . 1990 Mol. Cell. Biol. 10: 4089–4099

  • Penner CG, Wang Z, Litchfield DW . 1997 J. Cell. Biochem. 64: 525–537

  • Pepperkok R, Lorenz P, Ansorge W, Pyerin W . 1994 J. Biol. Chem. 269: 6986–6991

  • Pepperkok R, Lorenz P, Jakobi R, Ansorge W, Pyerin W . 1991 Exp. Cell. Res. 197: 245–253

  • Pinna LA, Meggio F . 1997 Prog. Cell Cycle Res. 3: 77–97

  • Pouyssegur J, Sardet C, Franchi A, L'Allemain G, Paris S . 1984 Proc. Natl. Acad. Sci. USA 81: 4833–4837

  • Sardet C, Franchi A, Pouyssegur J . 1989 Cell 56: 271–280

  • Seldin DC, Leder P . 1995 Science 267: 894–897

  • Snell V, Nurse P . 1994 EMBO J. 13: 2066–2074

  • Ulloa L, Diaz-Nido J, Avila J . 1993 EMBO J. 12: 1633–1640

  • Vilk G, Saulnier RB, St Pierre R, Litchfield DW . 1999 J. Biol. Chem. 274: 14406–14414

  • Wakabayashi S, Fafournoux P, Sardet C, Pouyssegur J . 1992 Proc. Natl. Acad. Sci. USA 89: 2424–2428

  • Zeng YX, Somasundaram K, Prabhu NS, Krishnadasan R, el-Deiry WS . 1997 Biotechniques 23: 88, 90, 92, 94

Download references

Acknowledgements

N Le Guern and C Catteau are gratefully acknowledged for expert technical assistance. We thank J Pouyssegur for providing the Na+/H+ exchanger-deficient PS120 cells and SM Keyse for the pSG5/Pyst1-HA plasmid. We thank D Birnbaum and T Buchou for fruitful discussions and critical reading of the manuscript. This work was supported by the Institut National de la Santé et de la Recherche Médicale (INSERM), the Commissariat à l'Energie Atomique (CEA), the Centre National de la Recherche Scientifique (CNRS), the Association pour la Recherche sur le Cancer, the Fondation pour la Recherche Médicale, the Ligue Nationale Française contre le Cancer and the Commission of the European Community (Biomed 2).

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lebrin, F., Chambaz, E. & Bianchini, L. A role for protein kinase CK2 in cell proliferation: evidence using a kinase-inactive mutant of CK2 catalytic subunit α. Oncogene 20, 2010–2022 (2001). https://doi.org/10.1038/sj.onc.1204307

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204307

Keywords

This article is cited by

Search

Quick links